In the near future, a prostate cancer patient in Missouri may be injected with a radioisotope that can help imaging scanners accurately determine the precise location of a tumor. That diagnostic imagery could also help determine the targeting ability and exact therapeutic dose necessary to destroy the cancer cells without harming other tissues or organs in the body. A physician could then deliver to that patient a therapeutic radioisotope that is toxic to the cancer cells, without all of the physical side effects of treatments such as chemotherapy.
Professor of Radiology Jeff Smith and Chemistry Professor Silvia Jurisson chat outside the International Institute of Nano and Molecular Medicine (INMI), across the street from the MU Research Reactor (MURR). The INMI facility will provide critical infrastructure and collaborative expertise to researchers at all four University of Missouri campuses.
At the beginning of the school year, University of Missouri System President Mun Choi announced a series of investments in research and creative works that will help the system’s four universities achieve excellence through innovation. Many of those innovations will germinate and take root at the Institute of Nano and Molecular Innovations (INMI) building across the street from the MU Research Reactor (MURR) on the Mizzou campus.